TGFB1 and systemic sclerosis: Many different hypothesis can be invoked to explain this finding including modulation at the receptor level [11], as increased expression of TGFβ1 receptors are reported in skin fibroblasts of SSc and LS patients [12-14] and continued production of TGFβ1 by endothelial cells as a repair/wound healing response in inactive lesions.